Numinus Wellness

Numinus Wellness

Company that markets psychedelic psychotherapy for mental health problems.

Launch date
Employees
Market cap
€6.4m
Enterprise valuation
€9m (Public information from Sep 2024)
Vancouver British Columbia (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
CAD2019202020212022202320242025
Revenues<1m<1m1.5m6.5m23.2m27.2m32.9m
% growth-720 %72 %329 %257 %17 %21 %
EBITDA(6.7m)(6.6m)(15.2m)(26.5m)(24.6m)--
% EBITDA margin(6212 %)(748 %)(1001 %)(408 %)(106 %)--
Profit(7.3m)(9.6m)(18.8m)(44.9m)(30.3m)--
% profit margin(6762 %)(1090 %)(1240 %)(691 %)(131 %)--
R&D budget<1m<1m1.4m1.9m1.2m--
R&D % of revenue138 %21 %93 %29 %5 %--
  • Edit
DateInvestorsAmountRound

$4.5m

Early VC
N/A

N/A

IPO
N/A

$17.3m

Post IPO Equity
*

CAD6.0m

Post IPO Equity
Total Funding€4.1m

Recent News about Numinus Wellness

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Numinus Wellness

Edit
Novamind
ACQUISITION by Numinus Wellness Apr 2022
Neurology Centre of Toronto
ACQUISITION by Numinus Wellness Jul 2021